Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs Dollar Tree, Inc. (DLTR) Price & Performance

BridgeBio Pharma IncTrade
Dollar Tree, Inc.Trade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs Dollar Tree, Inc. — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Dollar Tree, Inc. trades at $128.1 (market cap $24.61B). The key difference: Dollar Tree, Inc. is the larger of the two by market cap. Which is the better fit depends on your goals.

BBIODLTR
Market Cap
$16.36B$24.61B
Sector
HealthHealth
52-Week High
$90.17$141.21
52-Week Low
$47.29$85.04
Enterprise Value
$18.14B$31.20B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About Dollar Tree, Inc.

Dollar Tree operates discount stores in the U.S. and Canada, including 8,647 shops under its namesake banner and 8,016 Family Dollar units (as of the end of fiscal 2021). The eponymous chain features branded and private-label goods, generally at a $1.25 price. Around 45% of Dollar Tree stores' fiscal 2021 sales came from consumables (including food, health and beauty, and household paper and cleaning products), nearly 50% from variety items (including toys and housewares), and just over 5% from seasonal goods. Family Dollar features branded and private-label goods at prices generally ranging from $1 to $10, with over 76% of fiscal 2021 sales from consumables, 9% from seasonal/electronic items (including prepaid phones and toys), 8% from home products, and 6% from apparel and accessories.

Read more on DLTR